GENinCode (LON:GENI) Trading 0.5% Higher – Time to Buy?

GENinCode Plc (LON:GENI)’s share price traded up 0.5% during mid-day trading on Friday . The company traded as high as GBX 1.10 and last traded at GBX 0.95. 3,773,302 shares traded hands during mid-day trading, a decline of 29% from the average session volume of 5,290,828 shares. The stock had previously closed at GBX 0.95.

GENinCode Price Performance

The business’s 50-day moving average price is GBX 0.87 and its 200 day moving average price is GBX 1.02. The company has a market capitalization of £7.19 million, a P/E ratio of -0.46 and a beta of 0.56. The company has a quick ratio of 15.88, a current ratio of 0.93 and a debt-to-equity ratio of 117.74.

GENinCode (LON:GENI) last posted its earnings results on Monday, June 8th. The company reported GBX (2.08) earnings per share for the quarter. GENinCode had a negative return on equity of 409.40% and a negative net margin of 185.47%.The firm had revenue of GBX 308 million for the quarter. Analysts anticipate that GENinCode Plc will post -7.1299999 EPS for the current fiscal year.

GENinCode Company Profile

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.